Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $348.49 million. The enterprise value is $292.73 million.
| Market Cap | 348.49M |
| Enterprise Value | 292.73M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, before market open.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 248.92 million shares outstanding. The number of shares has increased by 22.05% in one year.
| Shares Outstanding | 248.92M |
| Shares Change (YoY) | +22.05% |
| Shares Change (QoQ) | +0.16% |
| Owned by Insiders (%) | 11.72% |
| Owned by Institutions (%) | 64.53% |
| Float | 122.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.14 |
| PS Ratio | 55.98 |
| Forward PS | 57.70 |
| PB Ratio | 2.94 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 47.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.99, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.99 |
| Quick Ratio | 2.80 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -204.90 |
Financial Efficiency
Return on equity (ROE) is -62.20% and return on invested capital (ROIC) is -79.43%.
| Return on Equity (ROE) | -62.20% |
| Return on Assets (ROA) | -48.50% |
| Return on Capital (ROIC) | -79.43% |
| Revenue Per Employee | $30,817 |
| Profits Per Employee | -$474,772 |
| Employee Count | 202 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -458,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.89% in the last 52 weeks. The beta is 1.77, so Precigen's price volatility has been higher than the market average.
| Beta (1Y) | 1.77 |
| 52-Week Price Change | +23.89% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 1.35 |
| Relative Strength Index (RSI) | 49.12 |
| Average Volume (30 Days) | 1,004,508 |
Short Selling Information
The latest short interest is 15.96 million, so 6.41% of the outstanding shares have been sold short.
| Short Interest | 15.96M |
| Short Previous Month | 16.90M |
| Short % of Shares Out | 6.41% |
| Short % of Float | 13.03% |
| Short Ratio (days to cover) | 17.16 |
Income Statement
In the last 12 months, Precigen had revenue of $6.23 million and -$95.90 million in losses. Loss per share was -$0.39.
| Revenue | 6.23M |
| Gross Profit | 106,000 |
| Operating Income | -99.76M |
| Pretax Income | -96.36M |
| Net Income | -95.90M |
| EBITDA | -89.23M |
| EBIT | -95.89M |
| Loss Per Share | -$0.39 |
Balance Sheet
The company has $62.86 million in cash and $7.10 million in debt, giving a net cash position of $55.76 million or $0.22 per share.
| Cash & Cash Equivalents | 62.86M |
| Total Debt | 7.10M |
| Net Cash | 55.76M |
| Net Cash Per Share | $0.22 |
| Equity / Book Value | 118.50M |
| Book Value Per Share | 0.48 |
| Working Capital | 45.77M |
Cash Flow
In the last 12 months, operating cash flow was -$66.93 million and capital expenditures -$1.44 million, giving a free cash flow of -$68.37 million.
| Operating Cash Flow | -66.93M |
| Capital Expenditures | -1.44M |
| Free Cash Flow | -68.37M |
| FCF Per Share | -$0.28 |
Margins
Gross margin is 1.70%, with operating and profit margins of -1,602.54% and -1,540.63%.
| Gross Margin | 1.70% |
| Operating Margin | -1,602.54% |
| Pretax Margin | -1,547.98% |
| Profit Margin | -1,540.63% |
| EBITDA Margin | -1,433.35% |
| EBIT Margin | -1,540.47% |
| FCF Margin | -1,098.28% |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.05% |
| Shareholder Yield | -22.05% |
| Earnings Yield | -27.52% |
| FCF Yield | -19.62% |
Analyst Forecast
The average price target for Precigen is $10.00, which is 614.29% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.00 |
| Price Target Difference | 614.29% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 141.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -13.47 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -13.47 |
| Piotroski F-Score | 3 |